ReviewCurrent diabetes reports2012
Quality of life and technology: impact on children and families with diabetes.
Review in Current diabetes reports, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
26 citing papers in PubMed, 2 syntheses or guidelines pooled it, 70 citations in OpenAlex.
- Usability of Continuous Glucose Monitoring for Older Adults with Type 2 Diabetes: A Systematic Review.Diabetes technology & therapeutics · 2026Pooled it
- Pooled it
- Effect of diabetes self-management education on health-related quality of life of Tunisian children with type1 diabetes mellitus and their parents: A randomized controlled trial.La Tunisie medicale · 2024Trial
- Parent Perspectives of School/Daycare Experiences in Young Children Newly Diagnosed With Diabetes.Journal of pediatric psychology · 2023Trial
- Effectiveness of a WeChat Combined Continuous Flash Glucose Monitoring System on Glycemic Control in Juvenile Type 1 Diabetes Mellitus Management: Randomized Controlled Trial.Diabetes, metabolic syndrome and obesity : targets and therapy · 2021Trial
- Reduced Diabetes Burden Over Glycemic Gains With the Dexcom G7 Upgrade in Youth on Automated Insulin Delivery System.Diabetes, obesity & metabolism · 2026Article
- Article
- Article
- Article
- Patient Perspectives on the Benefits and Challenges of Diabetes and Digital Technology.Clinical diabetes : a publication of the American Diabetes Association · 2024Article
- The Impact of Virtual Care on Health-Related Quality of Life in Pediatric Diabetes Mellitus: A Systematic Review.Adolescent health, medicine and therapeutics · 2024Review
- Toward Diabetes Device Development That Is Mindful to the Needs of Young People Living With Type 1 Diabetes: A Data- and Theory-Driven Qualitative Study.JMIR diabetes · 2023Article
- Psychosocial Outcomes with the Omnipod® 5 Automated Insulin Delivery System in Children and Adolescents with Type 1 Diabetes and Their Caregivers.Pediatric diabetes · 2023Article
- ISPAD Clinical Practice Consensus Guidelines 2022: Psychological care of children, adolescents and young adults with diabetes.Pediatric diabetes · 2022Article
- Improving the Patient Experience With Longer Wear Infusion Sets Symposium Report.Journal of diabetes science and technology · 2022Article
- Psychological Characteristics and Goals of Caregivers Choosing Continuous Glucose Monitoring for Children With Type 1 Diabetes.Diabetes spectrum : a publication of the American Diabetes Association · 2022Article
- Oral Health Status of Children Living with Type 1 Diabetes Mellitus.International journal of environmental research and public health · 2022Article
- Using an mHealth App to Transition Care of Type 1 Diabetes from Parents to Teens: Protocol for a Pilot Study.JMIR research protocols · 2018Article
- Biopsychosocial Factors Associated With Satisfaction and Sustained Use of Artificial Pancreas Technology and Its Components: a Call to the Technology Field.Current diabetes reports · 2018Review
- Automated Insulin Delivery Systems: Hopes and Expectations of Family Members.Diabetes technology & therapeutics · 2018Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 1 institution in 1 country.
Funding
Abstract
Ensuring quality of life (QOL) while maintaining glycemic control within targets is an important challenge in type 1 and type 2 diabetes treatment. For children with diabetes, QOL includes enjoying meals, feeling safe in school, and perceiving positive, supportive relationships with parents, siblings, and friends. Yet many treatment-related and psychosocial barriers can interfere with a child's QOL and their ability to manage diabetes effectively. Diabetes management also imposes considerable lifestyle demands that are difficult and often frustrating for children to negotiate at a young age. Recent advances in diabetes medications and technologies have improved glycemic control in children with diabetes. Two widely used technologies are the insulin pump and continuous glucose monitoring (CGM) system. These technologies provide patients with more flexibility in their daily life and information about glucose fluctuations. Several studies report improvements in glycemic control in children with type 1 diabetes using the insulin pump or sensor-augmented pump therapy. Importantly, these technologies may impact QOL for children and families with diabetes, although they are rarely used or studied in the treatment of children with type 2 diabetes. Further, emerging closed loop and web- and phone-based technologies have great potential for supporting diabetes self-management and perhaps QOL. A deeper understanding and appreciation of the impact of diabetes technology on children's and parents' QOL is critical for both the medical and psychological care of diabetes. Thus, the purpose of this review is to discuss the impact of new diabetes technologies on QOL in children, adolescents and families with type 1 diabetes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.